US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.